New EU commission chief Jean-Claude Juncker has defended his decision to shift the health technology and pharmaceutical policy services back to the more lobby-friendly internal market directorate - a move that has been criticised by MEPs and NGOs.
In the last Barroso commission, the units dealing with medical devices, health technology and cosmetics were part of DG Sanco - the health directorate. Juncker's reorganisation of the commission services has moved these units back to internal ...
Back our independent journalism by becoming a supporting member
Already a member? Login here